Canadian CDMO adds spray drying to support ‘poorly soluble drugs’

By Flora Southey contact

- Last updated on GMT

Genvion has invested approximately $1.5m in spray drying and coating technology for solid dosage forms at its manufacturing facility in Canada.

The contract development and manufacturing organisation (CDMO) has added on-line spray dryers and Wurster coaters to its 80,000 sq. ft. site in Winnipeg, Manitoba.

The investment will see the firm offer spray drying services in R&D and manufacturing for commercial production.

According to Genvion, the investment responds to increased demand for spray drying and drug layering services.

“Customer demand for GMP (good manufacturing practice) spray drying is increasing because of the need to support poorly soluble drugs,” ​said vice president Tony Cocci in a statement.

“Market response to the investment in our capabilities has been very encouraging,” ​he added.

Related topics: Processing, Processing equipment

Related news

Related products

The battle of performance in pharma production

The battle of performance in pharma production

Telstar Life Science Solutions | 26-Mar-2019 | Case Study

Telstar case study. Discover how a versatile freeze-dryer automatic loading & unloading systemDiscover how a versatile freeze-dryer automatic loading...

Accelerate your supply chain as pressures intensify

Accelerate your supply chain as pressures intensify

William Reed | 17-Sep-2018 | Technical / White Paper

Food, Drink and Non-Food manufacturers are under pressure. Range reviews, massive retail mergers, the backlash against plastic packaging and the ongoing...


Optimizing vessel geometry for mag drive agitators

Steridose, Inc | 14-Sep-2017 | Technical / White Paper

The performance of a bottom mount magnetically driven agitator (mag drive mixer) is heavily dependent on its relationship with the vessel’s geometry, baffles,...

Related suppliers